UIPATH INC - CLASS A (PATH) Fundamental Analysis & Valuation

NYSE:PATH • US90364P1057

Current stock price

12.06 USD
-0.18 (-1.47%)
At close:
12.1722 USD
+0.11 (+0.93%)
After Hours:

This PATH fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. PATH Profitability Analysis

1.1 Basic Checks

  • PATH had positive earnings in the past year.
  • In the past year PATH had a positive cash flow from operations.
  • PATH had negative earnings in 4 of the past 5 years.
  • In multiple years PATH reported negative operating cash flow during the last 5 years.
PATH Yearly Net Income VS EBIT VS OCF VS FCFPATH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 2026 0 200M -200M -400M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 8.88%, PATH belongs to the top of the industry, outperforming 84.89% of the companies in the same industry.
  • PATH has a Return On Equity of 13.56%. This is in the better half of the industry: PATH outperforms 79.50% of its industry peers.
  • With a decent Return On Invested Capital value of 2.13%, PATH is doing good in the industry, outperforming 66.91% of the companies in the same industry.
Industry RankSector Rank
ROA 8.88%
ROE 13.56%
ROIC 2.13%
ROA(3y)1.09%
ROA(5y)-5.83%
ROE(3y)1.7%
ROE(5y)-7.87%
ROIC(3y)N/A
ROIC(5y)N/A
PATH Yearly ROA, ROE, ROICPATH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 2026 0 -50 -100 -150 -200 -250

1.3 Margins

  • PATH's Profit Margin of 17.53% is amongst the best of the industry. PATH outperforms 83.45% of its industry peers.
  • PATH has a better Operating Margin (3.80%) than 67.27% of its industry peers.
  • With an excellent Gross Margin value of 83.21%, PATH belongs to the best of the industry, outperforming 88.85% of the companies in the same industry.
  • In the last couple of years the Gross Margin of PATH has remained more or less at the same level.
Industry RankSector Rank
OM 3.8%
PM (TTM) 17.53%
GM 83.21%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.06%
GM growth 5Y-1.37%
PATH Yearly Profit, Operating, Gross MarginsPATH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 2026 0 50 -50 -100 -150

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. PATH Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PATH is destroying value.
  • The number of shares outstanding for PATH has been reduced compared to 1 year ago.
  • Compared to 5 years ago, PATH has more shares outstanding
  • PATH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
PATH Yearly Shares OutstandingPATH Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M 500M
PATH Yearly Total Debt VS Total AssetsPATH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 2026 1B 2B 3B

2.2 Solvency

  • PATH has an Altman-Z score of 3.85. This indicates that PATH is financially healthy and has little risk of bankruptcy at the moment.
  • PATH's Altman-Z score of 3.85 is fine compared to the rest of the industry. PATH outperforms 72.30% of its industry peers.
  • PATH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3.85
ROIC/WACC0.19
WACC11%
PATH Yearly LT Debt VS Equity VS FCFPATH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 2026 0 500M 1B 1.5B 2B

2.3 Liquidity

  • PATH has a Current Ratio of 2.48. This indicates that PATH is financially healthy and has no problem in meeting its short term obligations.
  • PATH's Current ratio of 2.48 is fine compared to the rest of the industry. PATH outperforms 67.99% of its industry peers.
  • A Quick Ratio of 2.48 indicates that PATH has no problem at all paying its short term obligations.
  • PATH has a better Quick ratio (2.48) than 68.70% of its industry peers.
Industry RankSector Rank
Current Ratio 2.48
Quick Ratio 2.48
PATH Yearly Current Assets VS Current LiabilitesPATH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B 2B 2.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. PATH Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 33.33% over the past year.
  • Measured over the past years, PATH shows a very strong growth in Earnings Per Share. The EPS has been growing by 68.69% on average per year.
  • PATH shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.65%.
  • The Revenue has been growing by 21.53% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)33.33%
EPS 3Y68.69%
EPS 5YN/A
EPS Q2Q%15.38%
Revenue 1Y (TTM)12.65%
Revenue growth 3Y15.01%
Revenue growth 5Y21.53%
Sales Q2Q%13.56%

3.2 Future

  • PATH is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -1.64% yearly.
  • Based on estimates for the next years, PATH will show a quite strong growth in Revenue. The Revenue will grow by 10.52% on average per year.
EPS Next Y8.02%
EPS Next 2Y7.97%
EPS Next 3Y-10.27%
EPS Next 5Y-1.64%
Revenue Next Year10.58%
Revenue Next 2Y9.57%
Revenue Next 3Y9.08%
Revenue Next 5Y10.52%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
PATH Yearly Revenue VS EstimatesPATH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 500M 1B 1.5B 2B 2.5B
PATH Yearly EPS VS EstimatesPATH Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0.2 0.4 0.6 0.8

More info and screens

Find the best growth stocksShow best growing peers

4

4. PATH Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 16.75, which indicates a correct valuation of PATH.
  • 78.42% of the companies in the same industry are more expensive than PATH, based on the Price/Earnings ratio.
  • PATH's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.23.
  • Based on the Price/Forward Earnings ratio of 15.51, the valuation of PATH can be described as correct.
  • Based on the Price/Forward Earnings ratio, PATH is valued a bit cheaper than 74.82% of the companies in the same industry.
  • PATH is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.42, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 16.75
Fwd PE 15.51
PATH Price Earnings VS Forward Price EarningsPATH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as PATH.
  • Based on the Price/Free Cash Flow ratio, PATH is valued a bit cheaper than 75.90% of the companies in the same industry.
Industry RankSector Rank
P/FCF 18.31
EV/EBITDA 56
PATH Per share dataPATH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PATH does not grow enough to justify the current Price/Earnings ratio.
  • A cheap valuation may be justified as PATH's earnings are expected to decrease with -10.27% in the coming years.
PEG (NY)2.09
PEG (5Y)N/A
EPS Next 2Y7.97%
EPS Next 3Y-10.27%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PATH Dividend Analysis

5.1 Amount

  • No dividends for PATH!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PATH Fundamentals: All Metrics, Ratios and Statistics

UIPATH INC - CLASS A

NYSE:PATH (3/20/2026, 8:16:08 PM)

After market: 12.1722 +0.11 (+0.93%)

12.06

-0.18 (-1.47%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)03-11
Earnings (Next)05-27
Inst Owners74.83%
Inst Owner Change1.44%
Ins Owners9.41%
Ins Owner Change-2.43%
Market Cap6.45B
Revenue(TTM)1.61B
Net Income(TTM)282.33M
Analysts67.14
Price Target16.49 (36.73%)
Short Float %24.17%
Short Ratio2.79
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.46%
Min EPS beat(2)7.4%
Max EPS beat(2)15.53%
EPS beat(4)4
Avg EPS beat(4)28.49%
Min EPS beat(4)7.36%
Max EPS beat(4)83.69%
EPS beat(8)8
Avg EPS beat(8)27.32%
EPS beat(12)12
Avg EPS beat(12)71.21%
EPS beat(16)16
Avg EPS beat(16)86.55%
Revenue beat(2)2
Avg Revenue beat(2)2.06%
Min Revenue beat(2)1.55%
Max Revenue beat(2)2.57%
Revenue beat(4)4
Avg Revenue beat(4)2.81%
Min Revenue beat(4)1.55%
Max Revenue beat(4)5.03%
Revenue beat(8)6
Avg Revenue beat(8)1.21%
Revenue beat(12)9
Avg Revenue beat(12)1.58%
Revenue beat(16)13
Avg Revenue beat(16)2.55%
PT rev (1m)-1.57%
PT rev (3m)3.14%
EPS NQ rev (1m)4.75%
EPS NQ rev (3m)6.06%
EPS NY rev (1m)0.33%
EPS NY rev (3m)2.59%
Revenue NQ rev (1m)0.94%
Revenue NQ rev (3m)1.07%
Revenue NY rev (1m)1.01%
Revenue NY rev (3m)2.92%
Valuation
Industry RankSector Rank
PE 16.75
Fwd PE 15.51
P/S 4
P/FCF 18.31
P/OCF 17.37
P/B 3.1
P/tB 3.33
EV/EBITDA 56
EPS(TTM)0.72
EY5.97%
EPS(NY)0.78
Fwd EY6.45%
FCF(TTM)0.66
FCFY5.46%
OCF(TTM)0.69
OCFY5.76%
SpS3.01
BVpS3.89
TBVpS3.62
PEG (NY)2.09
PEG (5Y)N/A
Graham Number7.94
Profitability
Industry RankSector Rank
ROA 8.88%
ROE 13.56%
ROCE 2.69%
ROIC 2.13%
ROICexc 6.03%
ROICexgc 7.37%
OM 3.8%
PM (TTM) 17.53%
GM 83.21%
FCFM 21.87%
ROA(3y)1.09%
ROA(5y)-5.83%
ROE(3y)1.7%
ROE(5y)-7.87%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.06%
GM growth 5Y-1.37%
F-Score8
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 112.25%
Cap/Sales 1.18%
Interest Coverage 250
Cash Conversion 475.08%
Profit Quality 124.73%
Current Ratio 2.48
Quick Ratio 2.48
Altman-Z 3.85
F-Score8
WACC11%
ROIC/WACC0.19
Cap/Depr(3y)77.11%
Cap/Depr(5y)89.47%
Cap/Sales(3y)0.93%
Cap/Sales(5y)1.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)33.33%
EPS 3Y68.69%
EPS 5YN/A
EPS Q2Q%15.38%
EPS Next Y8.02%
EPS Next 2Y7.97%
EPS Next 3Y-10.27%
EPS Next 5Y-1.64%
Revenue 1Y (TTM)12.65%
Revenue growth 3Y15.01%
Revenue growth 5Y21.53%
Sales Q2Q%13.56%
Revenue Next Year10.58%
Revenue Next 2Y9.57%
Revenue Next 3Y9.08%
Revenue Next 5Y10.52%
EBIT growth 1Y144.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year17.9%
EBIT Next 3Y10.77%
EBIT Next 5Y12.97%
FCF growth 1Y15.22%
FCF growth 3YN/A
FCF growth 5Y68.42%
OCF growth 1Y15.8%
OCF growth 3YN/A
OCF growth 5Y66.31%

UIPATH INC - CLASS A / PATH Fundamental Analysis FAQ

What is the fundamental rating for PATH stock?

ChartMill assigns a fundamental rating of 6 / 10 to PATH.


What is the valuation status of UIPATH INC - CLASS A (PATH) stock?

ChartMill assigns a valuation rating of 4 / 10 to UIPATH INC - CLASS A (PATH). This can be considered as Fairly Valued.


What is the profitability of PATH stock?

UIPATH INC - CLASS A (PATH) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for PATH stock?

The Price/Earnings (PE) ratio for UIPATH INC - CLASS A (PATH) is 16.75 and the Price/Book (PB) ratio is 3.1.


What is the earnings growth outlook for UIPATH INC - CLASS A?

The Earnings per Share (EPS) of UIPATH INC - CLASS A (PATH) is expected to grow by 8.02% in the next year.